NCT06111755

Quit Smoking Text Message Study

Name: Clinical Trial NCT06111755
Creator: Yale University
Keywords: Smoking Cessation, SmokefreeTXT, other, clinical trial

Evaluating Digital Health Interventions To Promote Smoking Cessation

Yale University·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Smoking Cessation
Drug/Device/Intervention: SmokefreeTXT
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: Yale University

Timeline & enrollment

Phase: N/A
Start date: Nov 01, 2023
End date: Jun 01, 2025
Enrollment: 200 participants

Primary outcome

Number of participants with cotinine confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks)

Summary

This project will address research gaps and advance the science of smoking cessation by conducting a randomized controlled trial of an evidence-based, population-level quit smoking text messaging program with or without a smartband.

ICD-10 classifications

Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06111755
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06111755 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.